(4-imidazolyl)piperidines, the preparation thereof and their application
in therapy
    4.
    发明授权
    (4-imidazolyl)piperidines, the preparation thereof and their application in therapy 失效
    (4-咪唑基)哌啶,其制备及其在治疗中的应用

    公开(公告)号:US4707487A

    公开(公告)日:1987-11-17

    申请号:US840956

    申请日:1986-03-17

    CPC分类号: C07D401/04

    摘要: Compounds of general formula ##STR1## in which R.sub.1 denotes H, CH.sub.3 or C.sub.2 H.sub.5, R denotes H or R.sub.2 and R.sub.2 denotes an alkyl, piperonyl, 3-(1-benzimidazolonyl)-propyl group; a group of formula ##STR2## in which n is 0, 1, 2, or 3, X is a single bond or alternatively --O--, --S--, --NH--, --CO--, --CH.dbd.CH-- or ##STR3## and R.sub.3 is H, CH.sub.3, F, CN or an acyl group; or alternatively a group of formula ##STR4## in which Z denotes an O or S atom or a divalent group NH, N --CH.sub.3 or N --CN, and R.sub.5 denotes an alkyl group, a cycloalkyl group which can bear a phenyl substituent, a phenyl group which can bear a CH.sub.3 or F substituent, a phenylalkyl(1-3 C) group or a naphthyl, adamantyl or p-toluenesulphonyl group. These compounds are useful to control the release of cerebral histamine and to increase the rate of renewal of cerebral histamine.

    摘要翻译: 其中R 1表示H,CH 3或C 2 H 5的通式为I的化合物,R表示H或R 2,R 2表示烷基,胡椒基,3-(1-苯并咪唑啉酮基) - 丙基; 其中n为0,1,2或3的式为“IMAGE”的基团,X为单键或者为-O - , - S - , - NH - , - CO-, - CH = CH-或 - 并且R 3是H,CH 3,F,CN或酰基; 或另一组式为“IMAGE”的基团,其中Z表示O或S原子或二价基团NH,N -CH 3或N -CN,R 5表示烷基,可带有苯基取代基的环烷基, 可以具有CH3或F取代基的苯基,苯基烷基(1-3C)基或萘基,金刚烷基或对甲苯磺酰基。 这些化合物可用于控制脑组织胺的释放和增加脑组织的更新速率。

    Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same
    5.
    发明授权
    Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same 失效
    咪唑并吡啶衍生物,制备方法和含有其的药物组合物

    公开(公告)号:US07098220B2

    公开(公告)日:2006-08-29

    申请号:US10533699

    申请日:2003-11-04

    IPC分类号: C07D471/04 A61K31/44

    CPC分类号: C07D471/04

    摘要: Compounds of formula (I): wherein: R1 represents hydrogen, halogen, alkyl, polyhaloalkyl, cyano, nitro, hydroxycarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl, R2 represents hydrogen, alkyl, an optionally substituted aryl, optionally substituted heteroaryl, or R20—C(X)— wherein: R20 represents alkyl, alkoxy, amino, alkylamino, dialkylamino, optionally substituted aryl or optionally substituted heteroaryl, X represents oxygen, sulphur, or NR21 wherein R21 represents hydrogen or alkyl, R3 represents hydrogen atom or alkyl, n represents integer from 1 to 6 inclusive, the representation its enantiomers, diastereoisomers and also addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as AMPK activators.

    摘要翻译: 式(I)的化合物:其中:R 1表示氢,卤素,烷基,多卤代烷基,氰基,硝基,羟基羰基,烷氧基羰基,氨基羰基,烷基氨基羰基或二烷基氨基羰基R 2, 表示氢,烷基,任选取代的芳基,任选取代的杂芳基或R 20 -C(X) - 其中:R 20表示烷基,烷氧基,氨基,烷基氨基, 二烷基氨基,任选取代的芳基或任选取代的杂芳基,X表示氧,硫或NR 21,其中R 21表示氢或烷基,R 3, 表示氢原子或烷基,n表示1至6的整数,其表示其对映异构体,非对映异构体及其与药学上可接受的酸或碱的加成盐,以及含有它们的药物,可用作AMPK活化剂。